Obagi Medical Sets IPO Terms

Obagi Medical Products Inc., a Long Beach, Calif.-based pharma company focused on the aesthetic and therapeutic skin health markets, has set its proposed IPO terms to 5.35 million common shares being offered at between $13 and $15 per share. It plans to trade on the Nasdaq under ticker symbol OMPI, with JPMorgan serving as lead underwriter. Stonginton Partners is the company's majority shareholder. www.obagi.com